Floatz logo

Azacitidine

Relapse/Recurrence

Children's Hospital of Soochow UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Relapse/Recurrence cohort.

Asset / SponsorPhaseRating
cd19-ucart
Beijing Boren Hospital
Phase 2B
Venetoclax
Shenzhen University General Hospital
Phase 2CCC
Ifosfamide
Zhejiang Cancer Hospital
Phase 2CCC
ETOPOSIDE
Zhejiang Cancer Hospital
Phase 2CCC
Tirelizumab
Zhejiang Cancer Hospital
Phase 2CCC

View all 10 →

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →